Arkolith/Insider Trading/DYN/Form 4

Posner Brian S

DirectorDyne Therapeutics, Inc. (DYN) · full profile →Form 4 · filed Jun 9, 2026
Net Buying
Open-Market Buys
$34K
Open-Market Sells
$0
Net Open-Market Flow
$34K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 8, 2026Buy(P)2K$16.94$34K25K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 5, 2026Grant(A)35K—$035K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-264004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML